Your browser doesn't support javascript.
loading
Correction to: A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer.
Curigliano, Giuseppe; Shapiro, Geoffrey I; Kristeleit, Rebecca S; Abdul Razak, Albiruni R; Leong, Stephen; Alsina, Maria; Giordano, Antonio; Gelmon, Karen A; Stringer-Reasor, Erica; Vaishampayan, Ulka N; Middleton, Mark; Olszanski, Anthony J; Rugo, Hope S; Kern, Kenneth A; Pathan, Nuzhat; Perea, Rachelle; Pierce, Kristen J; Mutka, Sarah C; Wainberg, Zev A.
Afiliação
  • Curigliano G; Istituto Europeo di Oncologia, IRCCS, Milano, Italy. giuseppe.curigliano@ieo.it.
  • Shapiro GI; University of Milan, Milano, Italy. giuseppe.curigliano@ieo.it.
  • Kristeleit RS; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Abdul Razak AR; University College London, Cancer Institute, London, UK.
  • Leong S; Phase 1 Program, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Alsina M; University of Colorado Cancer Center, Aurora, CO, USA.
  • Giordano A; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Gelmon KA; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.
  • Stringer-Reasor E; BC Cancer, Vancouver, BC, Canada.
  • Vaishampayan UN; University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham, AL, USA.
  • Middleton M; University of Michigan/Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
  • Olszanski AJ; University of Oxford, Oxford, UK.
  • Rugo HS; Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Kern KA; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
  • Pathan N; Pfizer, San Diego, CA, USA.
  • Perea R; Pfizer, San Diego, CA, USA.
  • Pierce KJ; Pfizer, San Diego, CA, USA.
  • Mutka SC; Pfizer, Groton, CT, USA.
  • Wainberg ZA; Celcuity, Minneapolis, MD, USA.
Br J Cancer ; 128(2): 400, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36697966

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Br J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Br J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália